Cancer Biomarkers

cancer growth development biomarker implies a substance or method that is definite of the proximity of infection in the body. A biomarker may be an iota released by a cancer or a specific response of the body to the closeness of harm. Inherited, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer growth development assurance, perception, and the investigation of infection transmission. Such biomarkers is tried in non-prominently accumulated bio liquids like blood or fluid body substance.

Various quality and protein based biomarkers have recently been used in the end in open minded thought; including,

  • AFP (Liver Cancer)
  • BCR-ABL (Chronic Myeloid Leukemia)
  • BRCA1/BRCA2 (Breast/Ovarian Cancer)
  • BRAF V600E (Melanoma/Colorectal Cancer)

    Related Conference of Cancer Biomarkers

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in